Comparison between Ace Alpha Tech IPO and Sheel Biotech IPO.
Ace Alpha Tech IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Sheel Biotech IPO is a SME Bookbuilding proposed to list at NSE SME.
| Ace Alpha Tech IPO | Sheel Biotech IPO | |
|---|---|---|
| Logo |  | |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Narnolia Financial Services Ltd. | Narnolia Financial Services Ltd. |
| Registrar | Skyline Financial Services Pvt.Ltd. | Skyline Financial Services Pvt.Ltd. |
| Market Maker | SS Corporate Securities Ltd. | Mansi Share & Stock Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Ace Alpha Tech IPO is up to ₹30.40 Cr whereas the issue size of the Sheel Biotech IPO is up to ₹32.31 Cr. The final issue price of Ace Alpha Tech IPO is ₹69.00 per share and of Sheel Biotech IPO is ₹63.00 per share.
| Ace Alpha Tech IPO | Sheel Biotech IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹65.00 per share | ₹59.00 per share |
| Issue Price (Upper) | ₹69.00 per share | ₹63.00 per share |
| Issue Price (Final) | ₹69.00 per share | ₹63.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 2000 shares |
| Fresh Issue Size | 32,84,000 shares | 51,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹22.66 Cr | up to ₹32.31 Cr |
| OFS Issue Size | 11,22,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹7.74 Cr | up to ₹0.00 Cr |
| Issue Size Total | 44,06,000 shares | 51,28,000 shares |
| Issue Size Total (Amount) | up to ₹30.40 Cr | up to ₹32.31 Cr |
Ace Alpha Tech IPO opens on Jun 26, 2025, while Sheel Biotech IPO opens on Sep 30, 2025. The closing date of Ace Alpha Tech IPO and Sheel Biotech IPO is Jun 30, 2025, and Oct 03, 2025, respectively.
| Ace Alpha Tech IPO | Sheel Biotech IPO | |
|---|---|---|
| Anchor Bid Date | Jun 25, 2025 | Sep 29, 2025 |
| Issue Open | Jun 26, 2025 | Sep 30, 2025 |
| Issue Close | Jun 30, 2025 | Oct 03, 2025 |
| Basis Of Allotment (Tentative) | Jul 01, 2025 | Oct 06, 2025 |
| Initiation of Refunds (Tentative) | Jul 02, 2025 | Oct 07, 2025 |
| Credit of Share (Tentative) | Jul 02, 2025 | Oct 07, 2025 |
| Listing date (Tentative) | Jul 03, 2025 | Oct 08, 2025 |
| Anchor Lockin End date 1 | Jul 31, 2025 | Nov 05, 2025 |
| Anchor Lockin End date 2 | Sep 29, 2025 | Jan 04, 2026 |
Ace Alpha Tech IPO P/E ratio is 9.07, as compared to Sheel Biotech IPO P/E ratio of 8.86.
| Ace Alpha Tech IPO | Sheel Biotech IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)
| Company Financials (Restated)Sheel Biotech Ltd.'s revenue increased by 11% and profit after tax (PAT) rose by 2% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 55.8 | 96.99 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 43.9 | 71.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 9.07 | 8.86 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹121.15 Cr. | ₹128.22 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 82 | 13.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 63.67 | 16.34 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.21 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹7.60 | ₹7.11 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 47.91 | 13.59 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Ace Alpha Tech IPO Retail Individual Investors (RII) are offered 15,44,000 shares while in Sheel Biotech IPO retail investors are offered 15,44,000 shares. Qualified Institutional Buyers (QIB) are offered 8,80,000 shares in Ace Alpha Tech IPO and 10,26,000 shares in Sheel Biotech IPO.
| Ace Alpha Tech IPO | Sheel Biotech IPO | |
|---|---|---|
| Anchor Investor Reservation | 13,20,000 shares | 15,24,000 shares |
| Market Maker Reservation | 2,64,000 shares | 2,72,000 shares |
| QIB | 8,80,000 shares | 10,26,000 shares |
| NII | 6,62,000 shares | 7,74,000 shares |
| RII | 15,44,000 shares | 18,04,000 shares |
| Employee | 0 shares | |
| Others | ||
| Total | 44,06,000 shares | 51,28,000 shares |
Ace Alpha Tech IPO subscribed 101.75x in total, whereas Sheel Biotech IPO subscribed 15.97x.
| Ace Alpha Tech IPO | Sheel Biotech IPO | |
|---|---|---|
| QIB (times) | 67.06x | 19.73x |
| NII (times) | 170.79x | 25.92x |
| Big NII (times) | 31.64x | |
| Small NII (times) | 14.49x | |
| RII (times) | 91.92x | 9.56x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 101.75x | 15.97x |
